NIH to License Odyssey Thera for Molecular Libraries Roadmap Initiative
News Aug 19, 2005
Odyssey Thera, Inc. has announced the signing of an agreement with the National Institutes of Health (NIH) to advance the goals of the Molecular Libraries Roadmap Initiative.
Under the agreement, Odyssey Thera will provide the NIH Chemical Genomics Center (NCGC) with access to proprietary human cell lines with state-of-the-art technology for screening biochemical pathways in living cells.
The technology, known as PCA (protein-fragment complementation assays), provides fluorescence sensors of bio-molecular interactions inside human cells.
Since these interactions comprise the pathways that regulate human health and disease processes, the assays enable screening for small molecules with direct relevance for pharmaceutical discovery.
The NCGC will use high-tech systems to screen its repository of over 100,000 chemically diverse small molecules against these pathways.
"Odyssey's technology provides a completely novel strategy for probing targets and pathways inside human cells," said Jim Inglese, Ph.D., Deputy Director of the NCGC.
He adds, "This strategy complements the advances made by the NIH Chemical Genomics Center, and could result in the identification of novel probes and new therapeutic strategies."
"This agreement reflects our commitment to dramatically accelerate and improve the process of drug discovery," said Marnie L. MacDonald, Ph.D., President and CEO of Odyssey Thera.
He adds, "The NCGC is leading the way in chemical biology approaches that will facilitate the discovery of new and better targets and drugs."
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018